Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Pelles Sharon
23 années d'expérience
La clinique est certifiée :
| Israël | Turquie | Espagne | |
| Colectomie (résection du gros intestin) | de $20,500 | de $6,912 | de $18,000 |
| Chimiothérapie pour le cancer du sein | de $22,500 | de $1,200 | de $3,500 |
| Radiothérapie pour le cancer colorectal | - | de $7,000 | de $10,000 |
Directrice de l'institut des tumeurs gastro-intestinales au centre médical Sourasky – Dre Sharon Peled est spécialisée dans le traitement systémique des cancers de l'appareil digestif.
Le professeur Ofer Merimsky est un oncologue de premier plan, spécialiste des tumeurs des os et des tissus mous au centre médical Sourasky. Son expertise s'étend sur plusieurs décennies, avec des responsabilités de direction au sein de sociétés d'oncologie mondiales.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Robotic and laparoscopic sigmoid colectomy for cancer are standard, widely available procedures in Israeli hospitals. JCI-accredited centers in Tel Aviv and Jerusalem utilize the Da Vinci system for precise tumor removal. These minimally invasive techniques are the preferred standard for treating sigmoid adenocarcinoma.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization where oncologists like Dr. Ofer Merimsky collaborate with surgical teams for complex cases. Large facilities like Sourasky and Assuta handle over 30,000 and 92,000 operations per year respectively. This high volume suggests that surgical teams maintain a high degree of proficiency in minimally invasive techniques.
Patient Consensus: Patients note that the small incisions lead to much less pain compared to traditional open surgery. They often express relief at how quickly they can walk and eat again after the procedure.
Bowel function restoration and early mobilization define the Israeli sigmoid colectomy recovery timeline. Patients usually stay in the hospital for 3 to 7 days. Full functional recovery typically occurs within 4 to 8 weeks. Specialized centers often employ Enhanced Recovery After Surgery protocols to speed healing.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate in oncology treatments. This high performance is often linked to the extreme specialization of their surgeons. For example, Dr. Joseph Klauzner has over 45 years of experience in colorectal procedures. Choosing a facility with such established surgical leadership often ensures more predictable recovery milestones.
Patient Consensus: Patients emphasize that frequent walking is the best way to manage gas pain and restart digestion. Many note a significant wave of fatigue hitting 2 to 4 weeks after returning home.
Israeli medical centers like Sourasky, Assuta, and Hadassah maintain Joint Commission International accreditation for colon cancer care. These facilities prioritize multidisciplinary treatment for sigmoid adenocarcinoma. Patients access specialists trained at premier global institutions like the Royal Marsden and University of Toronto.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Hadassah manage immense patient volumes, exceeding 1,000,000 annual visits. This high frequency allows surgeons to refine techniques for complex sigmoid adenocarcinoma cases. Clinics like Assuta offer private-sector flexibility. This lets patients select specific senior surgeons for robotic-assisted colectomy procedures.
Patient Consensus: Patients note the seamless coordination during diagnostics, often completing biopsies and PET/CT scans within days. Many feel reassured by doctors who explain surgical steps in clear, empathetic English.
Most patients undergoing sigmoid cancer surgery in Israel do not require a permanent stoma. Israeli surgeons prioritize primary anastomosis to reconnect the healthy bowel directly. A temporary stoma may be used for 6 to 12 weeks to protect the new connection while it heals properly.
Bookimed Expert Insight: Israeli oncology centers like Sourasky perform over 34,000 operations annually with a 90% success rate. High-volume centers often utilize Enhanced Recovery After Surgery (ERAS) protocols. These protocols help patients achieve primary anastomosis without needing a defunctioning stoma by prioritizing pre-operative preparation. Choosing a surgeon with over 20 years of experience, such as Dr. Gideon Goldman, further improves outcomes.
Patient Consensus: Patients note that temporary stomas are often part of the healing process to prevent leaks. They emphasize that minimally invasive surgery made their recovery faster and helped them avoid a permanent stoma.
Potential complications from sigmoid colectomy include anastomotic leaks, surgical site infections, and ileus. Israeli hospitals manage these risks through Enhanced Recovery After Surgery protocols. Highly trained teams at Joint Commission International-accredited facilities use laparoscopic and robotic techniques to minimize postoperative trauma and improve outcomes.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report high success rates by combining surgical expertise with multidisciplinary oversight. Senior surgeons like Dr. Ron Greenberg and Dr. Joseph Klauzner specialize in minimally invasive colorectal procedures. This focus on laparoscopy significantly lowers the frequency of wound infections compared to traditional open surgery.
Patient Consensus: Patients emphasize the importance of walking soon after surgery to restart bowel function. Many recommend asking for stool tests if diarrhea occurs to rule out infections during recovery.
Israeli oncology centers perform staging work-up within 1 to 2 days of arrival. Diagnostic protocols include PET-CT, chest and abdominal CT, and CEA bloodwork. Surgery for sigmoid adenocarcinoma is usually scheduled within 7 to 14 days once the multidisciplinary tumor board approves the treatment plan.
Bookimed Expert Insight: While many believe surgery is the immediate step, Israeli centers like Sourasky Medical Center emphasize a multidisciplinary tumor board review first. Data shows these boards, featuring experts like Dr. Ron Greenberg and Dr. Ido Wolf, often refine the surgical approach. This can range from robotic-assisted resections to combining surgery with HIPEC for advanced cases, which significantly impacts long-term success rates.
Patient Consensus: Patients note it is vital to bring original pathology slides and digital imaging to avoid redundant diagnostic steps. Preparing these materials beforehand often helps secure an operation date within the first week of arrival.
Patients should plan for a 10 to 14 day stay in Israel for sigmoid cancer surgery. This timeframe includes 3 to 7 days of hospitalization and one week of local recovery. Most centers clear patients for international travel approximately 10 days after the procedure.
Bookimed Expert Insight: While basic recovery takes 14 days, choosing centers like Sourasky or Assuta often allows for robotic-assisted surgery. Data shows these clinics handle over 30,000 operations annually. This high volume typically correlates with more efficient discharge protocols and faster returns of bowel function.
Patient Consensus: Patients note it is critical to stay nearby for the first 2 weeks. They emphasize building flexibility into travel plans in case pathology results or wound healing require extra time.